MolGen to present evolved diagnostic offering at MEDICA

MolGen B.V., is preparing to attend MEDICA, November 15-18. MEDICA, the largest medical trade fair in the world. Over the years, this event has attracted several thousand exhibitors from more than 50 countries.

Each year, leading individuals from the fields of business, research, and politics attend this top-class event — alongside thousands of national and international experts and decision-makers from the sector. MolGen is looking forward to connecting with global leaders in clinical chemistry, molecular diagnostics, translational medicine, lab management, and other areas of breaking science in laboratory medicine.

MolGen plans to use the event as an opportunity to share its fast-growing brand with market leaders from various industries and showcase and demonstrate its latest products and services. During the event, MolGen will reveal how it has evolved its offerings to include technology, systems, reagents and consumables for human diagnostics and pharmaceutical sciences.

In the area of human diagnostics and pharmaceutical sciences, MolGen develops and globally markets an automated total solution for molecular workflows. Its extraction and testing solutions, products and equipment are designed to achieve increased automation, reduced time to result, high yields and reproducibility. The company provides accurate, fast throughput, easy to handle systems and products for next-generation research genetics.

This event coincides with the opening of MolGen’s recently opened US-based office in San Diego and its UK office in London. 

Niels Kruize, MolGen CCO, said: “Attending such a fantastic, innovative event will be the perfect opportunity to share our revolutionary set-ups and customisable workflows that help those in emerging markets conduct safer and economical diagnostics that ultimately improve the lives of people, animals, plants and our planet.”